Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Lin, Sen ^a,b   Liang, Yajie ^a   Zhang, Jiqiang ^a   Bian, Chen ^a   Zhou, Hongli ^b   Guo, Qiang ^a   Xiong, Ying ^a   Li, Shurong ^b   Su, Bingyin ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

Author keywords

Inflammation; Microglial cell; Optic nerve; Retinal ganglion cell; TRIF

Indexed keywords

BETA INTERFERON; I KAPPA B KINASE BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; NEUROMODULIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; 2 HYDROXY 4,4' DIAMIDINOSTILBENE, METHANESULFONATE SALT; 2-HYDROXY-4,4'-DIAMIDINOSTILBENE, METHANESULFONATE SALT; CYTOKINE; DIAGNOSTIC AGENT; STILBAMIDINE; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; MICROGLIA; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA GANGLION CELL; SURVIVAL RATE; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; MALE; METABOLISM; METHODOLOGY; MOUSE MUTANT; NERVE REGENERATION; NEWBORN; OPTIC NERVE DISEASE; PATHOLOGY; PHYSIOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAP-43 PROTEIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NERVE REGENERATION; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS; STILBAMIDINES;

EID: 84862822312     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-39     Document Type: Article

References (61)

1. Harel NY, Strittmatter SM. Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?. Nat Rev Neurosci 2006, 7:603-616. 10.1038/nrn1957, 2288666, 16858389.
2. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006, 7:617-627. 2693386, 16858390.
3. Schwab ME, Kapfhammer JP, Bandtlow CE. Inhibitors of neurite growth. Annu Rev Neurosci 1993, 16:565-595. 10.1146/annurev.ne.16.030193.003025, 7681638.
4. Yin Y, Cui Q, Li Y, Irwin N, Fischer D, Harvey AR, Benowitz LI. Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci Official J Soc Neurosci 2003, 23:2284-2293.
5. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 2000, 20:4615-4626.
6. Yin Y, Cui Q, Gilbert HY, Yang Y, Yang Z, Berlinicke C, Li Z, Zaverucha-do-Valle C, He H, Petkova V, et al. Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci USA 2009, 106:19587-19592. 10.1073/pnas.0907085106, 2780793, 19875691.
7. Yin Y, Henzl MT, Lorber B, Nakazawa T, Thomas TT, Jiang F, Langer R, Benowitz LI. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci 2006, 9:843-852. 10.1038/nn1701, 16699509.
8. Koprivica V, Cho KS, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF, He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 2005, 310:106-110. 10.1126/science.1115462, 16210539.
9. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L, Kramvis I, Sahin M, He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966. 10.1126/science.1161566, 2652400, 18988856.
10. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318. 10.1126/science.1110647, 15831717.
11. Wohl SG, Schmeer CW, Witte OW, Isenmann S. Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion. Investig Ophthalmol Vis Sci 2010, 51:2686-2696.
12. Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Investig Ophthalmol Vis Sci 2010, 51:6448-6460.
13. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989, 491:394-397. 10.1016/0006-8993(89)90078-4, 2765895.
14. Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987, 223:284-288. 10.1016/0014-5793(87)80305-8, 2822487.
15. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 1993, 150:2659-2667.
16. Fischer D, Petkova V, Thanos S, Benowitz LI. Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J Neurosci Official J Soc Neurosci 2004, 24:8726-8740.
17. Laflamme N, Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J Official Publ Federation Am Societies Exp Biol 2001, 15:155-163.
18. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006, 175:209-215. 10.1083/jcb.200606016, 2064562, 17060494.
19. Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, Kosaras B, Flavell R, Strittmatter SM, Volpe J, Sidman R, Vartanian T. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci Official J Soc Neurosci 2007, 27:13033-13041.
20. Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007, 9:1081-1088. 10.1038/ncb1629, 17704767.
21. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801. 10.1016/j.cell.2006.02.015, 16497588.
22. Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S, Xiang J, Li JC, Fang CQ, Wang JZ. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 2011, 31:593-605. 10.1038/jcbfm.2010.129, 3049514, 20700129.
23. Shen H, Tesar BM, Walker WE, Goldstein DR. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 2008, 181:1849-1858. 2507878, 18641322.
24. Weber A, Kirejczyk Z, Besch R, Potthoff S, Leverkus M, Hacker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death and Differentiation 2010, 17:942-951. 10.1038/cdd.2009.190, 20019748.
25. Yu M, Lam J, Rada B, Leto TL, Levine SJ. Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways. J Immunol 2011, 186:1180-1188. 10.4049/jimmunol.1001499, 3075875, 21148036.
26. Goldberg JL, Klassen MP, Hua Y, Barres BA. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 2002, 296:1860-1864. 10.1126/science.1068428, 12052959.
27. Nakazawa T, Morii H, Tamai M, Mori N. Selective upregulation of RB3/stathmin4 by ciliary neurotrophic factor following optic nerve axotomy. Brain Res 2005, 1061:97-106. 10.1016/j.brainres.2005.08.055, 16256088.
28. Hume DA, Perry VH, Gordon S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 1983, 97:253-257. 10.1083/jcb.97.1.253, 2112503, 6345555.
29. Chang M, Jin W, Sun SC. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat Immunol 2009, 10:1089-1095. 10.1038/ni.1777, 2748822, 19734906.
30. Lamoke F, Labazi M, Montemari A, Parisi G, Varano M, Bartoli M. Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina. Exp Eye Res 2011, 93:350-4. 10.1016/j.exer.2011.02.007, 21354136.
31. Lorber B, Howe ML, Benowitz LI, Irwin N. Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. Nat Neurosci 2009, 12:1407-1414. 10.1038/nn.2414, 2770175, 19855390.
32. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP, Goldberg JL. KLF family members regulate intrinsic axon regeneration ability. Science 2009, 326:298-301. 10.1126/science.1175737, 2882032, 19815778.
33. Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 2007, 27:12565-12576. 10.1523/JNEUROSCI.3027-07.2007, 18003835.
34. Hauk TG, Leibinger M, Muller A, Andreadaki A, Knippschild U, Fischer D. Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys. Invest Ophthalmol Vis Sci 2010, 51:459-464. 10.1167/iovs.09-4203, 19661221.
35. Shechter R, Ronen A, Rolls A, London A, Bakalash S, Young MJ, Schwartz M. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol 2008, 183:393-400. 10.1083/jcb.200804010, 2575781, 18981228.
36. Schaden H, Stuermer CA, Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol 1994, 25:1570-1578. 10.1002/neu.480251209, 7861120.
37. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 2002, 3:216-227. 10.1038/nrn752, 11994753.
38. Goldberg JL, Barres BA. The relationship between neuronal survival and regeneration. Annu Rev Neurosci 2000, 23:579-612. 10.1146/annurev.neuro.23.1.579, 10845076.
39. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643. 10.1126/science.1087262, 12855817.
40. Nikfar S, Rahimi R, Abdollahi M. A meta-analysis of the efficacy and tolerability of interferon-beta in multiple sclerosis, overall and by drug and disease type. Clin Ther 2010, 32:1871-1888. 10.1016/j.clinthera.2010.10.006, 21095482.
41. Maier K, Kuhnert AV, Taheri N, Sattler MB, Storch MK, Williams SK, Bahr M, Diem R. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am J Pathol 2006, 169:1353-1364. 10.2353/ajpath.2006.060159, 1780185, 17003491.
42. Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, Goto J, Shimizu T, Takatsu M, Sakurai Y, et al. IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010, 75:1423-1427. 10.1212/WNL.0b013e3181f8832e, 20826711.
43. Field R, Campion S, Warren C, Murray C, Cunningham C. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain, Behavior, and Immunity 2010, 24:996-1007. 10.1016/j.bbi.2010.04.004, 20399848.
44. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
45. Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics J Am Soc Exp Neuro Ther 2010, 7:354-365.
46. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169:6668-6672.
47. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003, 278:49751-49762. 10.1074/jbc.M305820200, 14519765.
48. Beutler B, Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003, 424:743-748. 10.1038/nature01889, 12872135.
49. Cui Y, Wu J, Jung SC, Park DB, Maeng YH, Hong JY, Kim SJ, Lee SR, Eun SY. Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation. Biol Pharm Bull 2010, 33:1814-1821. 10.1248/bpb.33.1814, 21048305.
50. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15:307-339. 10.1007/BF02740665, 9457704.
51. Vereyken EJ, Bajova H, Chow S, de Graan PN, Gruol DL. Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo. Eur J Neurosci 2007, 25:3605-3616. 10.1111/j.1460-9568.2007.05615.x, 17610580.
52. Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S. Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 2009, 50:452-461.
53. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A. Production and functions of IL-17 in microglia. J Neuroimmunol 2008, 194:54-61. 10.1016/j.jneuroim.2007.11.006, 18164424.
54. Sivakumar V, Foulds WS, Luu CD, Ling EA, Kaur C. Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J Pathol 2011, 224:245-260. 10.1002/path.2858, 21404274.
55. Dick AD, Ford AL, Forrester JV, Sedgwick JD. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c + CD4low parenchymal microglia. Br J Ophthalmol 1995, 79:834-840. 10.1136/bjo.79.9.834, 505270, 7488603.
56. Lee YS, Amadi-Obi A, Yu CR, Egwuagu CE. Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Immunology 2011, 132:492-502. 10.1111/j.1365-2567.2010.03379.x, 21294722.
57. Ethen CM, Hussong SA, Reilly C, Feng X, Olsen TW, Ferrington DA. Transformation of the proteasome with age-related macular degeneration. FEBS Lett 2007, 581:885-890. 10.1016/j.febslet.2007.01.061, 1850528, 17289037.
58. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, Ferrer I, Avila J, Lucas JJ. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci 2003, 23:11653-11661.
59. Kercher L, Favara C, Striebel JF, LaCasse R, Chesebro B. Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina and brain of transgenic mice. J Virol 2007, 81:10340-10351. 10.1128/JVI.00865-07, 2045503, 17652390.
60. Lagreze W. Treatment of optic neuropathies-state of the art. Klin Monbl Augenheilkd 2009, 226:875-880. 10.1055/s-0028-1109728, 19916146.
61. Selhorst JB, Chen Y. The optic nerve. Semin Neurol 2009, 29:29-35. 10.1055/s-0028-1124020, 19214930.